The function of glucosinolates in cancer prevention is mainly involved in activating the Nrf2 transcription factor, inhibiting tumor necrosis factor-α (TNFα) and interleukin-1β (IL-1β), inducing apoptosis, and modulating other specific inflammatory signaling pathways in cells [97]. This evidence concerns the gene TNF and cancer.